Cargando…
Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement
BACKGROUND: Cardiac light chain amyloidosis (AL-CA) patients often die within three months of starting chemotherapy. Chemotherapy for non-immunoglobulin M gammopathy with AL-CA frequently includes bortezomib (Bor), cyclophosphamide (Cy), and dexamethasone (D). We previously reported that NT-ProBNP l...
Autores principales: | Bézard, Mélanie, Oghina, Silvia, Vitiello, Damien, Kharoubi, Mounira, Kordeli, Ekaterini, Galat, Arnault, Zaroui, Amira, Guendouz, Soulef, Gilles, Floriane, Shourick, Jason, Hamon, David, Audard, Vincent, Teiger, Emmanuel, Poullot, Elsa, Molinier-Frenkel, Valérie, Lemonnier, François, Agbulut, Onnik, Le Bras, Fabien, Damy, Thibaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443042/ https://www.ncbi.nlm.nih.gov/pubmed/34525116 http://dx.doi.org/10.1371/journal.pone.0257189 |
Ejemplares similares
-
History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis
por: Kharoubi, Mounira, et al.
Publicado: (2021) -
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment
por: Oghina, Silvia, et al.
Publicado: (2021) -
Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2020) -
Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2023) -
Prevalence and determinants of iron deficiency in cardiac amyloidosis
por: Jobbé‐Duval, Antoine, et al.
Publicado: (2022)